documents: FDA-2026-N-10429-0003
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-N-10429-0003 | FDA | FDA-2026-N-10429 | Reference 2 - Brunt, T.M., ‘‘Rare but relevant: ibogaine and cardiovascular complications— prolonged QT interval and ventricular arrhythmias,’’ Addiction, 121(6):1616– 1621 (2026), available at doi:10.1111/add.70319. | Supporting & Related Material | Background Material | 2026-10-06T04:00:00Z | 2026 | 10 | 2026-10-06T20:44:30Z | 0 | 0 | 09000064b9635d75 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref